de Lange Christo, Coertzen Dina, Smit Frans J, Wentzel Johannes F, Wong Ho Ning, Birkholtz Lyn-Marie, Haynes Richard K, N'Da David D
Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom 2520, South Africa.
Department of Biochemistry, Genetics and Microbiology, Institute for Sustainable Malaria Control, University of Pretoria, Pretoria 0002, South Africa.
Bioorg Med Chem Lett. 2018 Oct 15;28(19):3161-3163. doi: 10.1016/j.bmcl.2018.08.037. Epub 2018 Aug 28.
Artemisinin-ferrocene conjugates incorporating a 1,2-disubstituted ferrocene analogous to that embedded in ferroquine but attached via a piperazine linker to C10 of the artemisinin were prepared from the piperazine artemisinin derivative, and activities were evaluated against asexual blood stages of chloroquine (CQ) sensitive NF54 and CQ resistant K1 and W2 strains of Plasmodium falciparum (Pf). The most active was the morpholino derivative 5 with IC of 0.86 nM against Pf K1 and 1.4 nM against Pf W2. The resistance indices were superior to those of current clinical artemisinins. Notably, the compounds were active against Pf NF54 early and late blood stage gametocytes - these exerted >86% inhibition at 1 µM against both stages; they are thus appreciably more active than methylene blue (∼57% inhibition at 1 µM) against late stage gametocytes. The data portends transmission blocking activity. Cytotoxicity was determined against human embryonic kidney cells (Hek293), while human malignant melanoma cells (A375) were used to assess their antitumor activity.
从哌嗪青蒿素衍生物制备了青蒿素-二茂铁缀合物,其包含与ferroquine中嵌入的二茂铁类似的1,2-二取代二茂铁,但通过哌嗪连接子连接到青蒿素的C10上,并针对氯喹(CQ)敏感的NF54以及CQ耐药的恶性疟原虫(Pf)K1和W2株的无性血液阶段评估了活性。活性最高的是吗啉代衍生物5,其对Pf K1的IC50为0.86 nM,对Pf W2的IC50为1.4 nM。耐药指数优于当前临床使用的青蒿素。值得注意的是,这些化合物对Pf NF54早期和晚期血液阶段配子体均有活性——它们在1 μM时对两个阶段的抑制率均>86%;因此,它们对晚期配子体的活性明显高于亚甲蓝(1 μM时约57%的抑制率)。这些数据预示着有传播阻断活性。测定了对人胚肾细胞(Hek293)的细胞毒性,同时用人恶性黑色素瘤细胞(A375)评估它们的抗肿瘤活性。